21-Jan-2026
Globe Newswire (Mon, 12-Jan 7:00 AM ET)
Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference
Globe Newswire (Wed, 7-Jan 7:30 AM ET)
Market Chameleon (Fri, 7-Nov 4:03 AM ET)
Sotera Health Announces Secondary Offering of Common Stock
Globe Newswire (Thu, 6-Nov 4:37 PM ET)
Sotera Health Reports Strong Third-Quarter and Year-to-Date 2025 Results
Globe Newswire (Tue, 4-Nov 7:00 AM ET)
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.
Sotera Health Company trades on the NASDAQ stock market under the symbol SHC.
As of January 21, 2026, SHC stock price climbed to $18.98 with 1,380,560 million shares trading.
SHC has a beta of 1.32, meaning it tends to be more sensitive to market movements. SHC has a correlation of 0.29 to the broad based SPY ETF.
SHC has a market cap of $5.38 billion. This is considered a Mid Cap stock.
Last quarter Sotera Health Company reported $311 million in Revenue and $.26 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.05.
In the last 3 years, SHC traded as high as $19.85 and as low as $9.53.
The top ETF exchange traded funds that SHC belongs to (by Net Assets): IJH, VTI, VB, VBK, VXF.
SHC has outperformed the market in the last year with a price return of +46.2% while the SPY ETF gained +15.9%. SHC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +13.6% and +1.3%, respectively, while the SPY returned +2.4% and -0.9%, respectively.
SHC support price is $18.37 and resistance is $19.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SHC shares will trade within this expected range on the day.